Iglesias, Adriana I.; van der Lee, Sven J.; Bonnemaijer, Pieter W. M. et al.
Haplotype reference consortium panel: Practical implications of imputations with large reference panelsHUMAN MUTATION. Bd. 38. H. 8. 2017 S. 1025-1032
Heinemann, Markus K.
Happy Birthday to You, Professor BorstTHORACIC AND CARDIOVASCULAR SURGEON. Bd. 65. H. 7. 2017 S. 503-504
Dietz, Julia; Vermehren, Johannes; Susser, Simone et al.
HCV resistance-associated substitutions in patients with HCV genotype 4 and failure to DAA combination therapies and implications for a retreatmentHEPATOLOGY. Bd. 66. 2017 S. 572A-573A
Juengel, Eva; Najafi, Ramin; Rutz, Jochen et al.
HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cellsONCOTARGET. Bd. 8. H. 66. 2017 S. 110016-110028
Stojanovic, N.; Hassan, Z.; Wirth, M. et al.
HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancerONCOGENE. Bd. 36. H. 13. 2017 S. 1804-1815
Zepp, F.
Health and EnvironmentMONATSSCHRIFT KINDERHEILKUNDE. Bd. 165. H. 5. 2017 S. 377-378
Golbidi, Saeid; Daiber, Andreas; Korac, Bato et al.
Health Benefits of Fasting and Caloric RestrictionCURRENT DIABETES REPORTS. Bd. 17. H. 12. 2017
Hammond, Edward R.; Friedel, Heiko; Garal-Pantaler, Elena et al.
Health Care Costs of Patients with Systemic Lupus Erythematosus (SLE) Versus Control Patients As a Function of Disease Severity: Analysis of the Betriebskrankenkassen German Sickness FundARTHRITIS & RHEUMATOLOGY. Bd. 69. 2017
Hess, Georg; Rule, Simon; Jurczak, Wojciech et al.
Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimusLEUKEMIA & LYMPHOMA. Bd. 58. H. 12. 2017 S. 2824-2832
Huber, Y.; Labenz, C.; Ganter, M. et al.
Health-related quality of life in patients with non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY. Bd. 66. H. 1. 2017 S. S597-S598